Sanofi
SNY
476 hedge funds and large institutions have $9.76B invested in Sanofi in 2015 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 121 increasing their positions, 200 reducing their positions, and 68 closing their positions.
92% more call options, than puts
Call options by funds: $24.5M | Put options by funds: $12.8M
0.81% less ownership
Funds ownership: 18.38% → 17.57% (-0.81%)
5% less funds holding
Funds holding: 499 → 476 (-23)
15% less capital invested
Capital invested by funds: $11.4B → $9.76B (-$1.69B)
26% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 68
40% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 200
56% less funds holding in top 10
Funds holding in top 10: 25 → 11 (-14)
Top Buyers
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$50.9M |
| 2 |
Morgan Stanley
New York
|
+$43.5M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$41.2M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$32.4M |
| 5 |
SM
Seminole Management
New York
|
+$28.3M |
Top Sellers
| 1 |
Neuberger Berman Group
New York
|
-$224M |
| 2 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
-$117M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.8M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$46.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$43.3M |
SNY Hedge Fund Activity: Q4 2015 in Review
476 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2015, worth a combined $9.76B — down 15% from $11.4B a quarter earlier.
Sellers outnumbered buyers: 68 funds closed out of SNY and 50 opened new positions — a net loss of 18 holders — while 200 trimmed existing stakes and 121 added.
The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $50.9M. The largest seller was Neuberger Berman Group, cutting an estimated $224M.
- 476 institutional investors held Sanofi (SNY) as of Q4 2015, down from 499 in Q3 2015.
- Funds reported $9.76B of Sanofi stock for Q4 2015, down 15% quarter-over-quarter.
- 50 funds opened new Sanofi positions in Q4 2015 and 68 closed out, a net change of -18 holders.
- The largest Sanofi buyer in Q4 2015 was Hotchkis & Wiley Capital Management, an estimated $50.9M added.
- The largest Sanofi seller in Q4 2015 was Neuberger Berman Group, an estimated $224M sold.
Based on aggregated 13F filings for Q4 2015.